|
|
|
|
|
Product Name
|
BACE1 antibody - Cytoplasmic domain
|
| |
See all BACE1 antibodies (14)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Rabbit polyclonal to BACE1 - Cytoplasmic domain
|
|
Immunogen
|
Synthetic peptide based on cytoplasmic domain of Human BACE1.
(Peptide available as ab41287.)
|
|
Reacts with
(species key)
|
Hu
|
|
Specificity
|
ab38893 recognizes all four of the splice variants of BACE1.
We have a range of domain specific antibodies for this target. For a full list please see all BACE1 antibodies
|
|
Tested applications
(see key)
|
WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions WB: 1/1000 - 1/5000. Detects a band of approximately 64 kDa (predicted molecular weight: 56 kDa). Notes: 1/1,000 when using colorimetric substrates such as BCIP/NBT and 1/5,000 for chemiluminescent substrates. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Cellular localization
|
Endoplasmic reticulum, Endosome, Golgi apparatus, Membrane
|
|
Research areas
|
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Aspartic protease >> BACEs Neuroscience >> Neurology process >> Neurodegenerative disease >> Alzheimer's disease >> Proteases
|
|
Relevance
|
BACE1 is a protease responsible for the proteolytic processing of the amyloid precursor protein (APP). Amyloid beta peptide is the major constituent of amyloid plaques in the brains of individuals afflicted with Alzheimers disease. This peptide is generated from the beta-amyloid precursor protein (beta APP) in a two-step process. The first step involves cleavage of the extracellular, amino-terminal domain of beta APP. Protein cleavage is performed by an aspartyl protease termed beta-secretase (BACE), of which there are two isoforms, BACE1 and 2. This enzyme is synthesized as a propeptide that must be modified to the mature and active form by the prohormone convertase furin. Beta APP cleavage by the mature form of BACE results in the cellular secretion of a segment of beta APP and a membrane-bound remnant. This remnant is then processed by another protease termed gamma-secretase. Gamma-secretase cleaves an intra-membrane site in the carboxyl-terminal domain of beta APP, thus generating the amyloid beta peptide.
|
|
|
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Rabbit
|
|
Clonality
|
Polyclonal
|
|
Isotype
|
IgG
|
|
Purity
|
Immunogen affinity purified
|
|
Storage buffer
|
Preservative: 0.05% Sodium Azide Constituents: 50% Glycerol Material safety datasheets (MSDS) for this product: Glycerol MSDS Sodium Azide MSDS
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Shipped at room temperature. Store at -20°C.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this BACE1 antibody - Cytoplasmic domain is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| |
|
Search PubMed (MEDLINE) for references to BACE1
|
| |
BACE1 antibody - Cytoplasmic domain - more information
|
Customer reviews (feedback) regarding BACE1 antibody - Cytoplasmic domain |
Customer FAQs regarding BACE1 antibody - Cytoplasmic domain |
Protocols for BACE1 antibody - Cytoplasmic domain |
Price and availability of products related to BACE1 antibody - Cytoplasmic domain |
| |
BACE1 antibody - Cytoplasmic domain - related products:
|
|
|
| |
BACE1 antibody - Cytoplasmic domain - other tools:
|
Contact Abcam with a Technical Enquiry about BACE1 antibody - Cytoplasmic domain |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"